Workup
Laboratory Studies
- Routine preoperative laboratory studies, including complete blood cell count, electrolyte assessment, blood urea nitrogen, and creatinine assessment, are obtained.
- Although no set level of serum creatinine precludes nephron-sparing surgery (NSS), the patient's baseline renal function is important. Not all patients with chronic renal insufficiency (CRI) require renal replacement therapy in the short term, and many can be treated medically for long periods.
- Radical nephrectomy can place the patient in need of immediate renal replacement therapy. If anatomically feasible, NSS can delay the onset of dialysis without compromising cancer care in the properly selected patient with CRI.
- The patient's blood should be typed and cross-matched.
- Other blood tests may include liver function tests and serum ferritin assessment, although tests to detect metastases are not always necessary in the small, incidentally detected mass that is amenable to partial nephrectomy.
Imaging Studies
- With the advent of modern imaging modalities, most renal cell carcinoma (RCC) is detected incidentally during CT scan performed with and without intravenous contrast or abdominal ultrasonography. Intravenous urography may not clearly define a small renal mass; therefore, other forms of confirmatory imaging are frequently required.
- The size, location, and characteristics of the renal mass (cystic vs solid) are assessed adequately with ultrasonography, CT scanning, and magnetic resonance imaging (MRI) of the abdomen.
- CT scanning and MRI of the abdomen can be beneficial to rule out metastatic or locally extensive disease.
- MRI also has a role in evaluating the inferior vena cava for the presence of tumor thrombus and its proximal and distal extent. Magnetic resonance angiography (MRA) also allows for excellent definition of the vascular anatomy and the segmental vascular anatomy for optimal surgical planning.
- Some surgeons have used intraoperative ultrasonography for evaluation of multifocality in select cases when preoperative imaging studies are equivocal or intraparenchymal nonpalpable tumors are suggested. Intraoperative ultrasonography can be a valuable adjunct in this setting. Its use is associated with a learning curve; however, this can be overcome with the aid of a radiologist or frequent use of the modality.
- Inferior and superior venacavography are not generally needed in the era of modern imaging. Furthermore, preoperative imaging modalities must delineate the relationship of the tumor to the normal surrounding parenchyma to allow for safe and adequate tumor excision while preserving maximal normal renal parenchyma.
- Although not essential in small peripherally located tumors, preoperative evaluation of the vasculature of the kidney and the tumor can aid in tumor excision. This is especially true of larger lesions and those that occupy a more central position close to the renal hilum, especially in a solitary kidney.
- In the past, renal angiography was used routinely to delineate vasculature. In the modern era, less invasive modalities, such as MRA, can be used to define anatomic relationships preoperatively.
- In addition, the use of 3-dimensional helical CT scan has provided important anatomical information concerning the renal vasculature and excretory function of the affected kidney. This technique better defines the relationship of the tumor with the collecting system and renal vasculature for preoperative surgical planning. In addition, it helps to anticipate tumor extension further so that operative complications can be minimized while obtaining the maximum surgical outcome. Small cuts through the tumor can be generated and the 3-dimensional reconstruction can aid in the surgical planning.
- In the unusual case in which the above studies fail to provide adequate imaging, conventional renal angiography can be of considerable value. Oblique views of the kidney may further delineate the segmental arteries.
- An important component of renal angiography is the venous phase of the study. Complete delineation of the renal arterial and venous vasculature is essential in the setting of a centrally located tumor in a solitary kidney.
- Chest radiography is indicated as a routine preoperative test.
- The role of PET scanning in RCC is not well established, although its role has been studied to a limited extent. The extent to which it can help in the identification of limited nodal disease is not well known. However, it has been used for monitoring the response to therapy (to interleukin-2) of the original tumor and metastatic sites. It may allow for the identification of appropriate marker lesions for further monitoring of therapy and can be yet another way to characterize tumors in patients with a complete response.
Diagnostic Procedures
- A dilemma exists with respect to the nature of the solid lesion prior to planned surgery. In a recent prospective study, 103 patients diagnosed with a solid renal mass on CT scan and scheduled for surgery were evaluated.2
- At the time of surgery, a biopsy sample of the surgical specimen was obtained under direct vision. Frozen section biopsy samples were compared to whole tissue specimens and reviewed by 2 pathologists.
- These experienced pathologists were able to diagnose only 3 out of 4 cases based on frozen section findings.
- Although the positive predictive value was excellent (94%), a large degree of inaccuracy existed for benign lesions, and many biopsy samples (approximately 22%) were nondiagnostic.
- The authors do not recommend routine use of intraoperative frozen section needle biopsy to guide surgical decision making. Percutaneous image-guided biopsies still have a role, especially to help rule out metastatic lesions. The information presented is clear evidence that, even under ideal biopsy circumstances, needle biopsy is insufficiently accurate (75%) in defining the nature of small renal lesions. For this reason, NSS with complete excision plays an important role for the small incidentally detected tumor because biopsy findings frequently do not change the surgical management.
More on Nephrectomy, Partial |
| Overview: Nephrectomy, Partial |
 Workup: Nephrectomy, Partial |
| Treatment: Nephrectomy, Partial |
| Follow-up: Nephrectomy, Partial |
| Multimedia: Nephrectomy, Partial |
| References |
| Further Reading |
| « Previous Page | Next Page » |
References
Ghavamian R, Cheville JC, Lohse CM, Weaver AL, Zincke H, Blute ML. Renal cell carcinoma in the solitary kidney: an analysis of complications and outcome after nephron sparing surgery. J Urol. Aug 2002;168(2):454-9. [Medline].
Dechet CB, Sebo T, Farrow G, Blute ML, Engen DE, Zincke H. Prospective analysis of intraoperative frozen needle biopsy of solid renal masses in adults. J Urol. Oct 1999;162(4):1282-4; discussion 1284-5. [Medline].
Belldegrun A, Tsui KH, deKernion JB, Smith RB. Efficacy of nephron-sparing surgery for renal cell carcinoma: analysis based on the new 1997 tumor-node-metastasis staging system. J Clin Oncol. Sep 1999;17(9):2868-75. [Medline].
Fergany AF, Hafez KS, Novick AC. Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup. J Urol. Feb 2000;163(2):442-5. [Medline].
Huang WC, Levey AS, Serio AM, Snyder M, Vickers AJ, Raj GV, et al. Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol. Sep 2006;7(9):735-40. [Medline].
Licht MR, Novick AC, Goormastic M. Nephron sparing surgery in incidental versus suspected renal cell carcinoma. J Urol. Jul 1994;152(1):39-42. [Medline].
Kletscher BA, Qian J, Bostwick DG, Andrews PE, Zincke H. Prospective analysis of multifocality in renal cell carcinoma: influence of histological pattern, grade, number, size, volume and deoxyribonucleic acid ploidy. J Urol. Mar 1995;153(3 Pt 2):904-6. [Medline].
Van Poppel H, Bamelis B, Oyen R, Baert L. Partial nephrectomy for renal cell carcinoma can achieve long-term tumor control. J Urol. Sep 1998;160(3 Pt 1):674-8. [Medline].
Lau WK, Blute ML, Weaver AL, Torres VE, Zincke H. Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney. Mayo Clin Proc. Dec 2000;75(12):1236-42. [Medline].
Tsui KH, Shvarts O, Smith RB, Figlin R, de Kernion JB, Belldegrun A. Renal cell carcinoma: prognostic significance of incidentally detected tumors. J Urol. Feb 2000;163(2):426-30. [Medline].
Dechet CB, Blute ML, Zincke H. Nephron sparing surgery for unilateral renal cell carcinoma: which variables contribute to contralateral recurrence?. J Urol. 1998;159:169 A.
Krejci KG, Blute ML, Cheville JC, Sebo TJ, Lohse CM, Zincke H. Nephron-sparing surgery for renal cell carcinoma: clinicopathologic features predictive of patient outcome. Urology. Oct 2003;62(4):641-6. [Medline].
Gill IS, Matin SF, Desai MM, Kaouk JH, Steinberg A, Mascha E, et al. Comparative analysis of laparoscopic versus open partial nephrectomy for renal tumors in 200 patients. J Urol. Jul 2003;170(1):64-8. [Medline].
Rogers CG, Singh A, Blatt AM, Linehan WM, Pinto PA. Robotic partial nephrectomy for complex renal tumors: surgical technique. Eur Urol. Mar 2008;53(3):514-23. [Medline].
Gettman MT, Blute ML, Chow GK, Neururer R, Bartsch G, Peschel R. Robotic-assisted laparoscopic partial nephrectomy: technique and initial clinical experience with DaVinci robotic system. Urology. Nov 2004;64(5):914-8. [Medline].
Gill IS, Novick AC, Meraney AM, Chen RN, Hobart MG, Sung GT, et al. Laparoscopic renal cryoablation in 32 patients. Urology. Nov 1 2000;56(5):748-53. [Medline].
Bosniak MA. The use of the Bosniak classification system for renal cysts and cystic tumors. J Urol. May 1997;157(5):1852-3. [Medline].
Butler BP, Novick AC, Miller DP, Campbell SA, Licht MR. Management of small unilateral renal cell carcinomas: radical versus nephron-sparing surgery. Urology. Jan 1995;45(1):34-40; discussion 40-1. [Medline].
Campbell SC, Novick AC, Streem SB, Klein E, Licht M. Complications of nephron sparing surgery for renal tumors. J Urol. May 1994;151(5):1177-80. [Medline].
Duffey BG, Choyke PL, Glenn G, Grubb RL, Venzon D, Linehan WM, et al. The relationship between renal tumor size and metastases in patients with von Hippel-Lindau disease. J Urol. Jul 2004;172(1):63-5. [Medline].
Gill IS, Hsu TH, Fox RL, Matamoros A, Miller CD, Leveen RF, et al. Laparoscopic and percutaneous radiofrequency ablation of the kidney: acute and chronic porcine study. Urology. Aug 1 2000;56(2):197-200. [Medline].
Hafez KS, Novick AC, Butler BP. Management of small solitary unilateral renal cell carcinomas: impact of central versus peripheral tumor location. J Urol. Apr 1998;159(4):1156-60. [Medline].
Hoh CK, Seltzer MA, Franklin J, deKernion JB, Phelps ME, Belldegrun A. Positron emission tomography in urological oncology. J Urol. Feb 1998;159(2):347-56. [Medline].
Lang EK. Comparison of dynamic and conventional computed tomography, angiography, and ultrasonography in the staging of renal cell carcinoma. Cancer. Nov 15 1984;54(10):2205-14. [Medline].
Lerner SE, Hawkins CA, Blute ML, Grabner A, Wollan PC, Eickholt JT, et al. Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery. J Urol. Jun 1996;155(6):1868-73. [Medline].
Morgan WR, Zincke H. Progression and survival after renal-conserving surgery for renal cell carcinoma: experience in 104 patients and extended followup. J Urol. Oct 1990;144(4):852-7; discussion 857-8. [Medline].
Ornstein DK, Lubensky IA, Venzon D, Zbar B, Linehan WM, Walther MM. Prevalence of microscopic tumors in normal appearing renal parenchyma of patients with hereditary papillary renal cancer. J Urol. Feb 2000;163(2):431-3. [Medline].
Russo P. Open partial nephrectomy: an essential contemporary operation. Nat Clin Pract Urol. Jan 2006;3(1):2-3. [Medline].
Steinbach F, Novick AC, Zincke H, Miller DP, Williams RD, Lund G, et al. Treatment of renal cell carcinoma in von Hippel-Lindau disease: a multicenter study. J Urol. Jun 1995;153(6):1812-6. [Medline].
Uzzo RG, Novick AC. Nephron sparing surgery for renal tumors: indications, techniques and outcomes. J Urol. Jul 2001;166(1):6-18. [Medline].
Walther MM, Lubensky IA, Venzon D, Zbar B, Linehan WM. Prevalence of microscopic lesions in grossly normal renal parenchyma from patients with von Hippel-Lindau disease, sporadic renal cell carcinoma and no renal disease: clinical implications. J Urol. Dec 1995;154(6):2010-4; discussion 2014-5. [Medline].
Zincke H, Ghavamian R. Partial nephrectomy for renal cell cancer is here to stay--more data on this issue. J Urol. Apr 1998;159(4):1161-2. [Medline].
Keywords
nephron-sparing surgery, NSS, RCC, renal cell carcinoma, renal parenchymal-sparing surgery, partial nephrectomy, radical nephrectomy, synchronous bilateral tumors, tumors in a solitary kidney, poorly functional contralateral renal unit, renal lesions, renal tumors, renal oncocytoma, renal angiomyolipoma, renal multilocular cyst, renal-preserving surgery, nephron-preserving surgery, hereditary papillary renal cell carcinoma, hereditary papillary RCC, von Hippel-Lindau syndrome, VHL syndrome, cystic renal neoplasm, solid renal neoplasm
